645 related articles for article (PubMed ID: 33782640)
1. The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review.
Rizkita LD; Astuti I
J Pharm Anal; 2021 Jun; 11(3):265-271. PubMed ID: 33782640
[TBL] [Abstract][Full Text] [Related]
2. MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies.
Panda M; Kalita E; Singh S; Kumar K; Rao A; Prajapati VK
Life Sci; 2022 Sep; 305():120761. PubMed ID: 35787998
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19.
Hum C; Loiselle J; Ahmed N; Shaw TA; Toudic C; Pezacki JP
Drugs; 2021 Apr; 81(5):517-531. PubMed ID: 33638807
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics.
Arman K; Dalloul Z; Bozgeyik E
Gene; 2023 Apr; 861():147232. PubMed ID: 36736508
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Host miRNA-223-3p to SARS-CoV-Induced Lung Inflammatory Pathology.
Morales L; Oliveros JC; Enjuanes L; Sola I
mBio; 2022 Apr; 13(2):e0313521. PubMed ID: 35229638
[TBL] [Abstract][Full Text] [Related]
6. miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery.
Alam T; Lipovich L
Noncoding RNA; 2021 Mar; 7(1):. PubMed ID: 33801496
[TBL] [Abstract][Full Text] [Related]
7. Computational prediction of potential siRNA and human miRNA sequences to silence orf1ab associated genes for future therapeutics against SARS-CoV-2.
Hasan M; Ashik AI; Chowdhury MB; Tasnim AT; Nishat ZS; Hossain T; Ahmed S
Inform Med Unlocked; 2021; 24():100569. PubMed ID: 33846694
[TBL] [Abstract][Full Text] [Related]
8. Small Non-coding RNAs: Do They Encode Answers for Controlling SARS-CoV-2 in the Future?
Bhattacharyya P; Biswas SC
Front Microbiol; 2020; 11():571553. PubMed ID: 33072032
[TBL] [Abstract][Full Text] [Related]
9. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.
Paul S; Bravo Vázquez LA; Reyes-Pérez PR; Estrada-Meza C; Aponte Alburquerque RA; Pathak S; Banerjee A; Bandyopadhyay A; Chakraborty S; Srivastava A
Virus Res; 2022 Jan; 308():198631. PubMed ID: 34788642
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas.
Bhavya ; Pathak E; Mishra R
J Endocrinol Invest; 2022 Mar; 45(3):537-550. PubMed ID: 34669152
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19.
Khan MA; Sany MRU; Islam MS; Islam ABMMK
Front Genet; 2020; 11():765. PubMed ID: 32765592
[TBL] [Abstract][Full Text] [Related]
12. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.
Pierce JB; Simion V; Icli B; Pérez-Cremades D; Cheng HS; Feinberg MW
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33207533
[TBL] [Abstract][Full Text] [Related]
13. Differentially-regulated miRNAs in COVID-19: A systematic review.
Ahmad W; Gull B; Baby J; Panicker NG; Khader TA; Akhlaq S; Rizvi TA; Mustafa F
Rev Med Virol; 2023 Jul; 33(4):e2449. PubMed ID: 37145095
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection.
Yang CY; Chen YH; Liu PJ; Hu WC; Lu KC; Tsai KW
Int J Med Sci; 2022; 19(8):1340-1356. PubMed ID: 35928726
[TBL] [Abstract][Full Text] [Related]
15. Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19).
Arora S; Singh P; Dohare R; Jha R; Ali Syed M
Gene; 2020 Dec; 762():145057. PubMed ID: 32805314
[TBL] [Abstract][Full Text] [Related]
16. Novel SARS-CoV-2 encoded small RNAs in the passage to humans.
Merino GA; Raad J; Bugnon LA; Yones C; Kamenetzky L; Claus J; Ariel F; Milone DH; Stegmayer G
Bioinformatics; 2021 Apr; 36(24):5571-5581. PubMed ID: 33244583
[TBL] [Abstract][Full Text] [Related]
17. Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells.
Wu YH; Yeh IJ; Phan NN; Yen MC; Hung JH; Chiao CC; Chen CF; Sun Z; Hsu HP; Wang CY; Lai MD
J Microbiol Immunol Infect; 2021 Oct; 54(5):845-857. PubMed ID: 34176764
[TBL] [Abstract][Full Text] [Related]
18. microRNA Heterogeneity, Innate-Immune Defense and the Efficacy of SARS-CoV-2 Infection-A Commentary.
Lukiw WJ
Noncoding RNA; 2021 Jun; 7(2):. PubMed ID: 34207055
[TBL] [Abstract][Full Text] [Related]
19. Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection.
Saçar Demirci MD; Adan A
PeerJ; 2020; 8():e9369. PubMed ID: 32547891
[TBL] [Abstract][Full Text] [Related]
20. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.
Meng F; Siu GK; Mok BW; Sun J; Fung KSC; Lam JY; Wong NK; Gedefaw L; Luo S; Lee TMH; Yip SP; Huang CL
Cells; 2021 Jul; 10(7):. PubMed ID: 34359932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
